Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.
Sign up for the Good Day BIO Newsletter >
June 3-6, 2024 | San Diego, CA
January 8-12, 2024 San Francisco, CA
February 26-27, 2024 New York, NY
March 18-20, 2024 Barcelona, Spain
Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.
Our tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.
Bringing you daily news at the intersection of biotechnology, politics, patients & the planet.
BIO and PhRMA submitted joint comments on the U.S. Food and Drug Administration’s Information Technology Strategy (Docket No. FDA-2023-N-3636)
BIO and PhRMA submitted joint comments on the U.S. Food and Drug Administration’s Information Technology Strategy (Docket No. FDA-2023-N-3636)